ArticleBJUI compass2020

Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label study.

Rodolfo Hurle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.